1/45
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai |
|---|
No analytics yet
Send a link to your students to track their progress
sepsis
_____ is life-threatening organ dysfunction caused by a dysregulated host response to infection
septic shock
_____ _____ is persistent hypotension requiring vasopressors to maintain mean arterial pressure (MAP) >65 mmHg and serum lactate >2 mmol/L despite having adequate volume resuscitation
-brain: altered mental status
-lungs: mechanical ventilation, hypoxemia
-heart: SBP <90, MAP <65 mmHg
-liver: T bilirubin >2 mg/dL, platelets <100,000, INR >1.5, aPTT >60
-kidneys: acute oliguria, UOP <0.5 ml/kg/hr despite fluids, elevated SCr
-gut: absent bowel sounds (ileus), abdominal pain
-skin: mottled and dusky
-lactate: >2 mmol/L
markers of organ dysfunction include:
-identify infection + organ dysfunction
-vitals: fever/hypothermia, tachycardia, hypotension, tachypnea, low SpO2
-perfusion: altered mentation, low UOP, mottled skin
-find source: lungs, urine, abdomen, skin/soft tissue
-labs: CBC, CMP, lactate, cultures x2, UA, procalcitonin, imaging as needed
-reassess frequently: MAP, mental status, UOP, repeat lactate
assessment of the septic patient includes:
leaky vessel syndrome, preload, vasodilation
_____ _____ _____ occurs in sepsis when inflammatory mediators damage endothelium; fluid and proteins shift out of the bloodstream and into tissues, leading to decreased intravascular volume (decreased ______); combined with sepsis-induced _______, SVR decreases and results in hypotension
performance improvement program
it is recommended to use a _____ _____ _____ for sepsis, including sepsis screening for acutely ill, high risk patients and standard operating procedures for treatment
SIRS, qSOFA
______ can be used as a single screening tool; the Surviving Sepsis Campaign does not recommend using ______ alone to screen for sepsis; instead, it supports using broader, systematic institutional screening approach to ensure early identification of patients with potential sepsis
lactate, 2
blood ______ should be measured in patients who are suspected of having sepsis; elevated level (>=___) increases likelihood of sepsis diagnosis
-temperature >100.4F (38C) or <96.8F (36C)
-heart rate >90 bpm
-respiratory rate >20 breaths per minute or PaCO2 <32 mmHg
-WBC >12,000 or <4,000/microliters or over 10% immature forms or bands
meeting SIRS criteria include 2 of the following, PLUS a suspected source of infection:
qSOFA
_______ is a bedside tool used to rapidly identify patients at risk for poor outcomes from infection
-RR >22 breaths/min
-altered mental status
-SBP < 100 mmHg
qSOFA criteria include:
2, assessment, intervention, diagnose
____ or more qSOFA points plus a suspected source of infection indicates that a patient is high risk; may indicate need for urgent ______, rapid _______, and sepsis bundle activation; doesn't ______ sepsis, but identifies patients at risk of poor outcomes
1 hour, 3 hours, procalcitonin, blood cultures
antibiotics should be administered within ____ _____ for patients in septic shock, and within ____ _____ for patients suspected of sepsis but not in shock; obtain ______, _____ ______, and work to get source control
empiric
______ antimicrobial selection is based on patient-specific risk factors
MRSA
if a patient is at high risk, ______ coverage should be included in empiric regimen; low risk do not need coverage; drugs include vancomycin, daptomycin (not in lungs!), or linezolid
-prior history of MRSA infection
-recent IV antibiotics
-history of recurrent skin infections or chronic wounds
-presence of invasive devices
-hemodialysis
-recent hospital admissions
-severity of illness
factors that put patients at high risk for MRSA:
false; you only double-cover if a patient is at high risk
true or false: you should double-cover for gram negative agents for all patients suspected of sepsis
pathogen, susceptibilities
in high risk patients, use two antimicrobials with gram-negative coverage for empiric treatment; however, do not double cover once causative _______ and _______ are known
-proven infection or colonization with resistant organisms in last year
-local prevalence of antibiotic resistant organisms
-hospital acquired infection
-broad spectrum antibiotic used in last 90 days
-travel to highly endemic country in last 90 days
-hospitalization within the last 90 days
-selective digestive decontamination (SDD)
factors that put patients at risk for MDR organisms, so require double coverage for gram negatives:
-piperacillin/tazobactam
-ceftazidime
-cefepime
-aztreonam
-imipenem
-meropenem
-doripenem
-ciprofloxacin
-levofloxacin
-polymyxin B
anti-pseudomonal agents include:
ciprofloxacin, levofloxacin
_______ and _______ can be used orally to treat Pseudomonas
antifungal, fluconazole, micafungin, amphotericin
for patients at high risk for Candida sepsis, initiate empiric therapy with ______ agent; do not initiate in low-risk patients; drugs include ______, ______, and ______; guidelines also include risk factors for endemic yeast and invasive mold infections
true
true or false: immunocompromised patients should receive bacterial, fungal, and viral empiric coverage if septic
small, influenza, SARS-CoV2
viruses comprise a _____ number of sepsis cases; causative infections include ______ and _______; no recommendation on use of antiviral therapy
-neutropenia
-HIV
-hematological malignancies
-stem cell or solid organ transplant
-recent travel to tropical regions
special populations to consider for antiviral therapy:
aminoglycosides, vancomycin
TDM is required for _______ and _______
daily, narrow, shorter
assess sepsis patients ______, and ______ spectrum as soon as possible using culture results; prefer _______ duration of therapy
procalcitonin
______ thresholds (% change in concentration) for discontinuation very across literature; obtain levels and use clinical evaluation
30, balanced crystalloid
____ mL/kg of IV ______ ______ fluid should be given within the first 3 hours
65
the MAP goal is >_____ to maintain perfusion
true
true or false: balanced crystalloids are preferred over normal saline for fluid resuscitation
albumin
_______ is indicated after patients have received large volumes of crystalloids
-passive leg raise
-fluid bolus
-stroke volume
-pulse pressure variation
-echocardiography
use dynamic measures such as these to guide fluid resuscitation:
-lactated ringers
-Plasmalyte
-Normosol
-Electroly S/R
balanced crystalloids include:
colloids
_______ contain larger molecules that may cause kidney injury if administered for fluid resuscitation
-hetastarch
-albumin
-dextran
-blood (PRBCs)
colloids include:
norepinephrine, vasopressin
our first-line vasoactive agent is going to be ________, and our second-line agent will be ________
a1, b1, arrythmia, extravasation
norepinephrine targets _____ receptors more than _____ receptors; it is indicated in most shock states besides _______; half-life is 1-2 minutes; decreases renal and splachnic perfusion, and has minimal adverse effect of _______; has a BBW for ______ reactions; available at most institutions as a pre-mixed infusion
epinephrine, arrythmia
______ targets B1, B2, and alpha receptors depending on dosage; second-line therapy in septic shock; half-life <5 minutes; more potential for _______ than norepinephrine
-V1: constriction of systemic, splanchnic, renal, and coronary arteries
-V2: antidiuretic effect
-V3: located on anterior pituitary and cause secretion of adrenocorticotropin hormone
Which receptors does vasopressin act on, and what are the effects?
second, 10-20
vasopressin is _____-line in septic shock and has a half-life of _____-_____ minutes
norepinephrine, vasopressin, dobutamine, epinephrine
use _______ as first-line agent for low MAP; consider adding ______ if map is still inadequate; consider adding _______ or switching to _______ (monotherapy) if cardiac dysfunction with persistent hypoperfusion is present despite adequate volume status and blood pressure
invasive, peripherally
use ______ monitoring (arterial line) over non-invasive monitoring; if no central access, consider initiating vasopressors ________ for a short amount of time (24-72 hours)
steroids, 4 hours
_______ are suggested for patients with septic shock and ongoing requirement for vasopressors; initiate at a dose of norepinephrine or epinephrine >0.25 mcg/kg/min at least _____ _____ after initiation
hydrocortisone
you can use IV corticosteroids, such as ______ 50 mg IV Q6H or continuous IV infusion (200 mg/day)
vitamin c
IV ____ ____ is not recommended for sepsis as there is low quality of supporting evidence